UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D
                    Under the Securities Exchange Act of 1934
                            (Amendment No. ________)*

                             BIOLASE TECHNOLOGY INC.
                                (Name of Issuer)

                                  COMMON STOCK
                         (Title of Class of Securities)

                                  TODD M. FICETO
                      9300 WILSHIRE BLVD., PENTHOUSE SUITE
                             BEVERLY HILLS, CA 90212
                                 (310) 286-2211
                -------------------------------------------------
                  (Name, Address and Telephone Number of Person
                Authorized to Receive Notices and Communications)

                                DECEMBER 14, 2005
             (Date of Event which Requires Filing of this Statement)

If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  that is the subject of this  Schedule  13D, and is filing this
schedule because of ss.ss.240.13d-1(e),  240.13d-1(f) or 240.13d-1(g), check the
following box. |_|

Note:  Schedules  filed in paper format shall include a signed original and five
copies of the  schedule,  including  all exhibits.  See  ss.240.13d-7  for other
parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).




                                  SCHEDULE 13D

CUSIP No.
---------------------------------------------------------------------
(1)  Names of Reporting Persons - Absolute Return Europe Fund
     I.R.S. Identification Nos. of above persons (entities only)
                                                N/A
---------------------------------------------------------------------
(2)  Check the Appropriate Box if a                          (A)  |X|
                                                                   -
     Member of a Group (See Instructions)                    (B)  |_|
---------------------------------------------------------------------
(3)  SEC Use Only
---------------------------------------------------------------------
(4)  Source of Funds (See Instructions) PF
---------------------------------------------------------------------
(5)  Check if Disclosure Of Legal Proceedings Is Required         |_|
     Pursuant to Items 2(d) OR 2(e)
---------------------------------------------------------------------
(6)  Citizenship or Place of Organization       Cayman Islands
---------------------------------------------------------------------
Number of Shares       (7)  Sole Voting Power
Beneficially
Owned by Each                                               1,200,000
Reporting Person       ----------------------------------------------
With                   (8)  Shared Voting Power

                       ----------------------------------------------
                       (9)  Sole Dispositive Power
                                                            1,200,000
                       ----------------------------------------------
                       (10) Shared Dispositive Power

---------------------------------------------------------------------
(11)  Aggregate Amount Beneficially Owned By Each Reporting
      Person                                                1,200,000
---------------------------------------------------------------------
(12)  Check if the Aggregate Amount In Row (11)                   |_|
      Excludes Certain Shares (See Instructions)
---------------------------------------------------------------------
(13)  Percent of Class Represented by Amount in Row (11)
                                                            5.1%
---------------------------------------------------------------------
(14)  Type of Reporting Person (See Instructions)           IA
---------------------------------------------------------------------

                                      -2-



ITEM 1. SECURITY AND ISSUER

State  the  title of the  class of equity  securities  to which  this  statement
relates  and the name and  address  of the  principal  executive  offices of the
issuer of such securities.

ITEM 2. IDENTITY AND BACKGROUND

If the person filing this statement or any person enumerated in Instruction C of
this  statement is a  corporation,  general  partnership,  limited  partnership,
syndicate or other group of persons, state its name, the state or other place of
its organization,  its principal  business,  the address of its principal office
and the information required by (d) and (e) of this Item.

If the person filing this statement or any person enumerated in Instruction C is
a natural person,  provide the information  specified in (a) through (f) of this
Item with respect to such person(s).

(a) Name;

(b) Residence or business address;

(c) Present principal  occupation or employment and the name, principal business
and address of any corporation or other organization in which such employment is
conducted;

(d) Whether or not,  during the last five years,  such person has been convicted
in a criminal proceeding  (excluding traffic violations or similar misdemeanors)
and, if so, give the dates,  nature of  conviction,  name and location of court,
and penalty imposed, or other disposition of the case;

(e)  Whether or not,  during the last five  years,  such person was a party to a
civil proceeding of a judicial or administrative body of competent  jurisdiction
and as a result of such  proceeding  was or is subject to a judgment,  decree or
final  order  enjoining  future  violations  of,  or  prohibiting  or  mandating
activities subject to, federal or state securities laws or finding any violation
with respect to such laws;  and, if so,  identify and describe such  proceedings
and summarize the terms of such judgment, decree or final order; and

(f) Citizenship.

ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION

State the source and the  amount of funds or other  consideration  used or to be
used in making the  purchases,  and if any part of the purchase price is or will
be represented by funds or other  consideration  borrowed or otherwise  obtained
for the  purpose of  acquiring,  holding,  trading or voting the  securities,  a
description  of the  transaction  and the names of the  parties  thereto.  Where
material,  such  information  should  also be  provided  with  respect  to prior
acquisitions not previously reported pursuant to this regulation.  If the source
of all or any  part of the  funds  is a loan  made  in the  ordinary  course  of
business by a bank,  as defined in Section  3(a)(6) of the Act,  the name of the
bank  shall not be made  available  to the  public if the  person at the time of
filing the statement so requests in writing and files such request,  naming such
bank,  with the Secretary of the  Commission.  If the  securities  were acquired
other than by purchase, describe the method of acquisition.

ITEM 4. PURPOSE OF TRANSACTION

State the purpose or purposes of the  acquisition  of  securities of the issuer.
Describe  any plans or  proposals  which the  reporting  persons  may have which
relate to or would result in:

(a) The acquisition by any person of additional securities of the issuer, or the
disposition of securities of the issuer;

(b) An extraordinary corporate transaction,  such as a merger, reorganization or
liquidation, involving the issuer or any of its subsidiaries;

(c) A sale or  transfer  of a material  amount of assets of the issuer or any of
its subsidiaries;

                                      -3-


(d) Any change in the present  board of directors or  management  of the issuer,
including any plans or proposals to change the number or term of directors or to
fill any existing vacancies on the board;

(e) Any material change in the present  capitalization or dividend policy of the
issuer;

(f) Any other material  change in the issuer's  business or corporate  structure
including  but  not  limited  to,  if  the  issuer  is a  registered  closed-end
investment company, any plans or proposals to make any changes in its investment
policy for which a vote is required by section 13 of the Investment  Company Act
of 1940;

(g) Changes in the issuer's charter, bylaws or instruments corresponding thereto
or other  actions which may impede the  acquisition  of control of the issuer by
any person;

(h) Causing a class of  securities  of the issuer to be delisted from a national
securities exchange or to cease to be authorized to be quoted in an inter-dealer
quotation system of a registered national securities association;

(i) A class of equity securities of the issuer becoming eligible for termination
of registration pursuant to Section 12(g)(4) of the Act; or

(j) Any action similar to any of those enumerated above.

Item 5. Interest in Securities of the Issuer

(a)  State the  aggregate  number  and  percentage  of the  class of  securities
identified  pursuant  to Item 1 (which may be based on the number of  securities
outstanding  as  contained  in the  most  recently  available  filing  with  the
Commission  by the issuer  unless the filing  person has reason to believe  such
information is not current)  beneficially  owned (identifying those shares which
there is a right to acquire) by each person named in Item 2.

The above mentioned information should also be furnished with respect to persons
who,  together  with any of the persons named in Item 2, comprise a group within
the meaning of Section 13(d)(3) of the Act;

(b) For each person named in response to paragraph  (a),  indicate the number of
shares as to which  there is sole  power to vote or to direct  the vote,  shared
power to vote or to direct  the vote,  sole  power to  dispose  or to direct the
disposition,  or shared power to dispose or to direct the  disposition.  Provide
the applicable  information  required by Item 2 with respect to each person with
whom the  power  to vote or to  direct  the vote or to  dispose  or  direct  the
disposition is shared;

(c) Describe any  transactions in the class of securities  reported on that were
effected  during the past sixty days or since the most recent filing of Schedule
13D  (ss.240.13d-191),  whichever is less,  by the persons  named in response to
paragraph (a).

(d) If any other  person is known to have the right to  receive  or the power to
direct the receipt of dividends  from,  or the  proceeds  from the sale of, such
securities,  a statement  to that effect  should be included in response to this
item and, if such interest relates to more than five percent of the class,  such
person  should be  identified.  A listing of the  shareholders  of an investment
company registered under the Investment Company Act of 1940 or the beneficiaries
of an employee benefit plan, pension fund or endowment fund is not required.

(e) If applicable, state the date on which the reporting person ceased to be the
beneficial owner of more than five percent of the class of securities.

ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSUER

Describe any contracts, arrangements,  understandings or relationships (legal or
otherwise)  among the persons  named in Item 2 and between  such persons and any
person with respect to any  securities of the issuer,  including but not limited
to transfer or voting of any of the securities,  finder's fees,  joint ventures,
loan or option arrangements,  puts or calls, guarantees of profits,  division of
profits or loss,  or the giving or  withholding  of proxies,  naming the persons
with whom such contracts,  arrangements,  understandings  or relationships  have
been entered into.  Include such  information for any of the securities that are
pledged or otherwise subject to a contingency the occurrence of which would give
another person voting power or investment power over such securities except that
disclosure  of  standard  default  and  similar  provisions  contained  in  loan
agreements need not be included.

                                      -4-


ITEM 7. MATERIAL TO BE FILED AS EXHIBITS

The following shall be filed as exhibits:  copies of written agreements relating
to the filing of joint acquisition statements as required by ss.240.13d-1(k) and
copies of all written agreements, contracts, arrangements, understandings, plans
or proposals  relating to: (1) the borrowing of funds to finance the acquisition
as disclosed in Item 3; (2) the acquisition of issuer control, liquidation, sale
of assets,  merger,  or change in business or  corporate  structure or any other
matter as disclosed in Item 4; and (3) the transfer or voting of the securities,
finder's  fees,  joint  ventures,  options,  puts,  calls,  guarantees of loans,
guarantees  against loss or of profit, or the giving or withholding of any proxy
as disclosed in Item 6.

Signature

After  reasonable  inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.

Date      12/19/2005

                                                   By:  /s/ Florian Homm
                                                        ------------------------
                                                   Name:  Florian Homm
                                                   Title: Investment Advisor


The  original  statement  shall be signed by each  person  on whose  behalf  the
statement is filed or his authorized representative.  If the statement is signed
on behalf of a person by his authorized  representative (other than an executive
officer  or  general   partner  of  the   filing   person),   evidence   of  the
representative's  authority to sign on behalf of such person shall be filed with
the  statement:  provided,  however,  that a power of attorney  for this purpose
which is already on file with the Commission may be  incorporated  by reference.
The name and any title of each person who signs the statement  shall be typed or
printed beneath his signature.

Attention:  Intentional  misstatements  or omissions of fact constitute  Federal
criminal violations (See 18 U.S.C. 1001)

                                       -5-